A new noninvasive test may be able to detect bladder cancer recurrence earlier than standard cytology and cystoscopy, according to new findings published online July 7 in the British Journal of Cancer ...

Treatment with UGN-102 in patients with recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer demonstrated beneficial responses. Patients with recurrent low-grade intermediate-risk ...

ZUSDURI's ENVISION trial shows a non-surgical, office-based option that reduces bladder cancer recurrence and improves patient quality of life.

Please provide your email address to receive an email when new articles are posted on . Patients with advanced muscle-invasive bladder cancer had lower risk for local recurrence with adjuvant ...

Analysis of Tumor Microenvironmental Features Between Primary and Synchronous Liver Metastases From Patients With Colorectal Cancers Using a Deep Learning Algorithm We present an automated tumor risk ...

Recurrences of low-, intermediate-, or high-/very high-risk tumors were again low, intermediate, or high risk in 74%, 62%, and 44% of cases, respectively. Recurrent non-muscle invasive bladder cancer ...

Two doses of a simple tuberculosis vaccination after surgery helps the immune system fight cancer cells and could greatly improve patient outcomes for the most common type of bladder cancer, according ...

New Delhi: Bladder cancer remains one of the most common urological cancers, yet early detection and monitoring of recurrence continue to challenge clinicians. New research now points to measurable ...

Trimodal therapy consisting of radiation plus chemotherapy and transurethral resection is an effective potential alternative to radical cystectomy for high-grade T1 bladder cancer. Trimodal therapy is ...

In a multi-institutional study published in Science Direct, researchers revealed that testing urine-based tumor DNA (utDNA) can help predict which bladder cancer patients are at higher risk for ...

Surgery for advanced bladder cancer includes transurethral resection of the bladder tumor (TURBT) to remove tumors and cystectomy to remove all or part of the bladder, with the choice depending on the ...

In the Phase 3 EV-304 trial, statistically significant improvements in overall survival and pathological complete response were also observed, with over half of patients having no detectable disease ...